C12N 2795/10344
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2795/10344 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 6 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 7
- Assignees
- 2
- Inventors
- 10
- Latest grant
- 9 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 2 |
| 2023 | 2 | 1 |
| 2024 | 2 | 3 |
By publication year.
Recent patents
- Production of lytic phages9 Apr 2024US 11,952,595 B2Eligo Bioscience
- Production bacterial cells and use thereof in production methods26 Mar 2024US 11,939,598 B2Eligo Bioscience
- Production of lytic phages29 Aug 2023US 11,739,304 B2Eligo Bioscience
- Production bacterial cells and use thereof in production methods11 Jul 2023US 11,697,802 B2Eligo Bioscience
- Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus4 Jul 2006US 7,070,930 B2GenVec, Inc.
- Production of lytic phages25 Jul 2024US 2024/0247238 A1Eligo Bioscience
- Production bacterial cells and use thereof in production methods6 Jun 2024US 2024/0182870 A1Eligo Bioscience
- Production of lytic phages11 Jan 2024US 2024/0010994 A1Eligo Bioscience
- Production bacterial cells and use thereof in production methods7 Sep 2023US 2023/0279364 A1Eligo Bioscience
- Production bacterial cells and use thereof in production methods17 Nov 2022US 2022/0364062 A1Eligo Bioscience
Most cited
By later US patents
- Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus4US 6,440,728 B1GenVec, Inc. · 2002
- Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus2US 7,070,930 B2GenVec, Inc. · 2006
- Production of lytic phages1US 11,739,304 B2Eligo Bioscience · 2023